These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 34367485)

  • 1. Alternative models of cancer stem cells: The stemness phenotype model, 10 years later.
    Kaushik V; Kulkarni Y; Felix K; Azad N; Iyer AKV; Yakisich JS
    World J Stem Cells; 2021 Jul; 13(7):934-943. PubMed ID: 34367485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stemness phenotype model.
    Cruz MH; Sidén A; Calaf GM; Delwar ZM; Yakisich JS
    ISRN Oncol; 2012; 2012():392647. PubMed ID: 22928120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stemness and plasticity of lung cancer cells: paving the road for better therapy.
    Luo J; Zhou X; Yakisich JS
    Onco Targets Ther; 2014; 7():1129-34. PubMed ID: 25018639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linking Tumor Microenvironment to Plasticity of Cancer Stem Cells: Mechanisms and Application in Cancer Therapy.
    Zheng X; Yu C; Xu M
    Front Oncol; 2021; 11():678333. PubMed ID: 34262865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells.
    Chanmee T; Ontong P; Kimata K; Itano N
    Front Oncol; 2015; 5():180. PubMed ID: 26322272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.
    Yadav AK; Desai NS
    Stem Cell Rev Rep; 2019 Jun; 15(3):331-355. PubMed ID: 30993589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cells in brain tumors: From origin to clinical implications.
    Lin S; Li K; Qi L
    MedComm (2020); 2023 Aug; 4(4):e341. PubMed ID: 37576862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell plasticity and heterogeneity in cancer.
    Marjanovic ND; Weinberg RA; Chaffer CL
    Clin Chem; 2013 Jan; 59(1):168-79. PubMed ID: 23220226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Road to stemness in hepatocellular carcinoma.
    Flores-Téllez TN; Villa-Treviño S; Piña-Vázquez C
    World J Gastroenterol; 2017 Oct; 23(37):6750-6776. PubMed ID: 29085221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipopolysaccharide supports maintaining the stemness of CD133(+) hepatoma cells through activation of the NF-κB/HIF-1α pathway.
    Lai FB; Liu WT; Jing YY; Yu GF; Han ZP; Yang X; Zeng JX; Zhang HJ; Shi RY; Li XY; Pan XR; Li R; Zhao QD; Wu MC; Zhang P; Liu JF; Wei LX
    Cancer Lett; 2016 Aug; 378(2):131-41. PubMed ID: 27208741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the Interplay Between Cancer Fibroblasts, Mesenchymal Stem Cells, and Cancer Stem Cells in Desmoplastic Cancers.
    Chan TS; Shaked Y; Tsai KK
    Front Oncol; 2019; 9():688. PubMed ID: 31417869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Mathematical Model of Average Dynamics in a Stem Cell Hierarchy Suggests the Combinatorial Targeting of Cancer Stem Cells and Progenitor Cells as a Potential Strategy against Tumor Growth.
    Molina-Peña R; Tudon-Martinez JC; Aquines-Gutiérrez O
    Cancers (Basel); 2020 Sep; 12(9):. PubMed ID: 32932755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy: Newer Therapeutic Armamentarium against Cancer Stem Cells.
    Singh SP; Singh R; Gupta OP; Gupta S; Brahma Bhatt ML
    J Oncol; 2020; 2020():3963561. PubMed ID: 32211043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer stem cells (CSCs): metabolic strategies for their identification and eradication.
    De Francesco EM; Sotgia F; Lisanti MP
    Biochem J; 2018 May; 475(9):1611-1634. PubMed ID: 29743249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic.
    Li WJ; Wang Y; Liu R; Kasinski AL; Shen H; Slack FJ; Tang DG
    Front Cell Dev Biol; 2021; 9():640587. PubMed ID: 33763422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing precision medicine panels for drug refractory cancers targeting cancer stemness traits.
    Warrier S; Patil M; Bhansali S; Varier L; Sethi G
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188475. PubMed ID: 33188876
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma.
    Kumar D; Gorain M; Kundu G; Kundu GC
    Mol Cancer; 2017 Jan; 16(1):7. PubMed ID: 28137308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Impact of Cancer Stem Cells.
    Lathia J; Liu H; Matei D
    Oncologist; 2020 Feb; 25(2):123-131. PubMed ID: 32043793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.